Keimyung University Dongsan Medical Center (DSMC) in South Korea is set to advance its cancer treatment capabilities with the introduction of RaySearch Laboratories’ RayStation and RayCare systems.

The installation of these systems at DSMC's new proton centre is set to commence in the second quarter of 2028, with the expectation to start treating first patients by the end of 2029.

DSMC's cancer centre aims to provide patient-centred care and is set to be the inaugural general hospital in the country to implement the ProTom Radiance 330 proton therapy system.

With this, DSMC will become the third proton centre in South Korea, following the National Cancer Center and Samsung Medical Center.

It will also be the first outside a metropolitan area, enhancing the accessibility of cancer treatment for patients in the area.

RaySearch founder and CEO Johan Löf said: “South Korea is an exciting market with some of the world’s most advanced radiation therapy facilities, and we see strong interest in RayStation and RayCare in the region.

“We are honoured by the trust placed in us by DSMC and look forward to continued collaboration with their organisation.”

The integration of RayStation and RayCare will streamline treatment planning and management of oncology information into a single workflow.

This encompasses the adoption of synchrotron-based proton pencil beam scanning therapy, a process that delivers precise radiation while protecting surrounding healthy tissue.

The method is particularly beneficial for treating cancers in sensitive areas and is expected to lessen side effects and enhance the quality of life for patients.

This development comes after Odense University Hospital in Denmark opted for RaySearch Laboratories' RayStation to enhance its treatment planning process in April.